Skip to main content


Page 4 of 4

  1. Oxygen is a World Health Organisation listed essential drug yet provision of oxygen in developing countries often fails to meet demand. The aim of this study was to evaluate the need for supplementary oxygen a...

    Authors: Hywel-Gethin Tudur Evans, Nadia Mahmood, Duncan G. Fullerton, Jamie Rylance, Andrew Gonani, Stephen B. Gordon, Kevin Mortimer and Theresa J. Allain
    Citation: Pneumonia 2016 1:1010003
  2. Childhood pneumonia continues to be the number one cause of death in children under five years of age in developing countries. In addition to mortality, pneumonia constitutes an enormous economic and social bu...

    Authors: Jukka Räsänen and Noam Gavriely
    Citation: Pneumonia 2014 5(Suppl 1):5010052

    This article is part of a Supplement: Volume 5 Supplement 1

  3. Despite the importance of paediatric pneumonia as a cause of short and long-term morbidity and mortality worldwide, a reliable gold standard for its diagnosis remains elusive. The utility of clinical, microbio...

    Authors: Kerry-Ann F. O’Grady, Paul J. Torzillo, Kieran Frawley and Anne B. Chang
    Citation: Pneumonia 2014 5(Suppl 1):5010038

    This article is part of a Supplement: Volume 5 Supplement 1

  4. Community-acquired pneumonia causes substantial morbidity and mortality in sub-Saharan Africa with an estimated 131 million new cases each year. Viruses — such as influenza virus, respiratory syncytial virus a...

    Authors: Antonia Ho
    Citation: Pneumonia 2014 5(Suppl 1):5010018

    This article is part of a Supplement: Volume 5 Supplement 1

  5. In well-resourced settings the systematic use of rapid diagnostics tests (e.g. pneumococcal urinary antigen test) that define the causal pathogen to direct therapy has not resulted in significantly improved ou...

    Authors: Stephen J. Aston
    Citation: Pneumonia 2014 5(Suppl 1):5010008

    This article is part of a Supplement: Volume 5 Supplement 1

  6. Community-acquired pneumonia (CAP) remains a common condition associated with considerable morbidity and mortality. Outcome is improved by early recognition and rapid institution of empirical antibiotic therap...

    Authors: Dan Wootton and Charles Feldman
    Citation: Pneumonia 2014 5(Suppl 1):5010001

    This article is part of a Supplement: Volume 5 Supplement 1

  7. Australian Aboriginal people have among the highest rates of invasive pneumococcal disease (IPD) worldwide. We investigated clinical diagnosis, risk factors, comorbidities and vaccine coverage in Aboriginal an...

    Authors: Faye J. Lim, Deborah Lehmann, Aoiffe McLoughlin, Catherine Harrison, Judith Willis, Carolien Giele, Anthony D. Keil and Hannah C. Moore
    Citation: Pneumonia 2014 4:4010024
  8. Context: The ideal duration of antibiotic treatment for childhood community acquired pneumonia (CAP) has not yet been established. Objective: A literature search was conducted to evaluate the efficacy of shorter ...

    Authors: Shalom Ben-Shimol, Varda Levy-Litan, Oana Falup-Pecurariu and David Greenberg
    Citation: Pneumonia 2014 4:4010016
  9. Pleural effusion is a serious complication of pneumonia, and Streptococcus pneumoniae is a leading cause. We describe the aetiology of pneumonia with effusion among children in the Dominican Republic before the i...

    Authors: Jesús Feris-Iglesias, Josefina Fernández, Jacqueline Sánchez, Fabiana Pimenta, Chabela Peña, Hilma Coradin, Eddy Perez-Then, Maria Peinado, Angélica Floren, Teresa Del Moral, Dean Erdman, Maria da Gloria Carvalho and Jennifer R. Verani
    Citation: Pneumonia 2014 4:4010008
  10. This review of pneumonia in the tropics is based on experience with respiratory infectons in Papua New Guinea since the 1970s. It discusses ideas, principles, historical aspects of pneumonia research and the n...

    Authors: Michael P. Alpers
    Citation: Pneumonia 2014 4:4010001
  11. Pneumonia is caused by respiratory bacteria and/or viruses. Little is known if co-infections are an aggravating factor in hospitalised children with severe pneumonia. We studied the impact of respiratory patho...

    Authors: Jean-Noel Telles, Nathalie Richard, Yves Gillet, Susanne Hartwig, Stéphane Pouzol, Sandra Dollet, Melina Messaoudi, Elodie Paredes, Christine Ploton, Gerard Lina, Guy Vernet, Daniel Floret, Etienne Javouhey and Gláucia Paranhos-Baccalà
    Citation: Pneumonia 2012 1:1010011
  12. Molecular methods offer improvement in the detection of causative pneumonia pathogens, but there are concerns of false positive results. Here we validate quantitative real-time PCR (qPCR) assays for the detect...

    Authors: Jana Y. R. Lai, Michael J. Binks, Mirjam Kaestli, Amanda J. Leach and Heidi C. Smith-Vaughan
    Citation: Pneumonia 2012 1:1010007

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 8.5
    5-year Journal Impact Factor: 5.9
    Source Normalized Impact per Paper (SNIP): N/A
    SCImago Journal Rank (SJR): N/A

    Speed 2023
    Submission to first editorial decision (median days): 11
    Submission to acceptance (median days): 122

    Usage 2023
    Downloads: 363,579
    Altmetric mentions: 274